Business Wire

The LYCRA Company Releases 2022 Planet Agenda Update , Reporting on Sustainability Progress Versus 2030 Goals

Share

The LYCRA Company, a global leader in developing durable, sustainable and innovative fiber and technology solutions for the apparel and personal care industries, announced today the publication of its second annual Planet Agenda Update and its abridged Global Sustainability Scorecard for fiscal year 2022. These documents report on the company's progress toward achieving its 2030 sustainability goals announced in last year's publication. Download them today on lycra.com/update.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230919391381/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The LYCRA Company reports on its sustainability progress in the 2022 Planet Agenda Update. (Photo: Business Wire)

Planet Agenda is the name of The LYCRA Company’s sustainability framework that touches every aspect of its business and is built on three pillars: product sustainability, manufacturing excellence and corporate responsibility. The sustainability goals outlined in these documents are organized around these pillars and align with five of the United Nations Sustainable Development Goals (SDGs). This update tracks 2022 performance against 2030 targets.

“Planet Agenda guides our evolution as we strive to contribute to the sustainability of the apparel and personal care industries by delivering products that add value and conserve resources at all levels of the value chain,” said Steve Stewart, chief brand and innovation officer, The LYCRA Company. “We are proud of the advances we have made in pursuit of our 2030 goals. At the same time, we recognize the challenges in front of our industry are great, and we can only meet them by working together with our customers, suppliers, and third-party partners.”

Highlights of the 2022 Planet Agenda Update include news on innovative products for sustainable fashion offering durability benefits, recycled and renewable inputs; a notable reduction in greenhouse gas emissions driven in part by the company’s Maydown, Northern Ireland site converting its purchased electricity to renewable sources through Energy Attribution Certificates (EACs); and three manufacturing sites achieving third-party verified top-quartile performance in the Higg Facility Environmental Module (FEM), with two achieving the same level in the Higg Facility Social & Labor Module (FSLM).

“We see Planet Agenda as a shared endeavor with our customers and partners, united in the belief that to have a healthy business we must have a healthy planet,” said Jean Hegedus, The LYCRA Company’s director of sustainable business development. “Our heritage of working together with our customers and other third parties, along with the urgent need for collaboration throughout the value chain in order to meet the industry’s goals, inspired the theme of the 2022 Planet Agenda Update: Together, we go further.”

To download a copy of the 2022 Planet Agenda Update or 2022 Global Sustainability Scorecard, visit lycra.com/update.

About The LYCRA Company

The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries and owns leading consumer and trade brands: LYCRA®, LYCRA HyFit®, LYCRA® T400®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX®, and TACTEL®. Headquartered in Wilmington, Delaware, The LYCRA Company is recognized worldwide for its innovative products, technical expertise, sustainable solutions, marketing support, and LYCRA ONE™ marketplace. The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. For more information, visit lycra.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Karie Ford
Karie.J.Ford@lycra.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ARMA Instruments Launch Zero Trust G1 Mark II Secure Messaging Communication Device3.10.2023 05:00:00 CEST | Press release

The Russian invasion of Ukraine has ignited an arms race in the theater of cyber warfare. Zero trust is the operative term for military, defense sectors, and governments across the globe. U.S. intelligence agencies and international partners recently published a report warning of the new Russian malware program Sandworm, likely targeting Ukrainian interests in its ongoing war, and U.S. defense agencies set a deadline of 2027 for implementation of zero trust cybersecurity environments [FedTech, August 2023]. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231002887540/en/ Switzerland-based ARMA Instruments AG announces the launch of their ARMA G1 Mark II Secure Messaging Device. Developed with zero trust principles, the device is a closed mobile system for person-to-person messaging at the highest security levels to counter advanced adversary attacks. The device will be beneficial for NGOs, defense agencies, cybersecurity oper

SLB Launches Carbon Storage Screening and Ranking Solution3.10.2023 04:00:00 CEST | Press release

SLB (NYSE: SLB) today launched its carbon storage screening and ranking solution that increases confidence in site selection decisions based on scientific analysis of the long-term integrity and economic potential of an asset. The solution helps customers avoid suboptimal storage sites with risk factors that can waste valuable time and resources as well as decrease the probability of a carbon capture, utilization and storage (CCUS) project reaching final investment decision (FID). “CCUS is one of the most immediate opportunities to reduce emissions, but it must scale up by 100–200 times in less than three decades to have the expected impact on global net zero ambitions,” said Frederik Majkut, senior vice president of Carbon Solutions for SLB’s New Energy business. “Ensuring that a storage site is both safer and economical is crucial for the speed, scale and investment needed to meaningfully drive CCUS growth for a low carbon energy ecosystem.” The screening and ranking solution uses bo

Takeda Provides Update on EXKIVITY ® (mobocertinib)2.10.2023 22:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA towards a voluntary withdrawal of EXKIVITY® (mobocertinib) in the U.S. for adult patients with epidermal growth factor receptor (EGFR) Exon20 insertion mutation-positive (insertion+) locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on or after platinum-based chemotherapy. Takeda intends to similarly initiate voluntary withdrawal globally where EXKIVITY is approved and is working with regulators in other countries where it is currently available on next steps. This decision was based on the outcome of the Phase 3 EXCLAIM-2 confirmatory trial, which did not meet its primary endpoint and thus did not fulfill the confirmatory data requirements of the Accelerated Approval granted by the U.S. FDA nor the conditional marketing approvals granted in other countries. The EXCLAIM-2 trial was a Phase 3

Galderma announces progress with RelabotulinumtoxinA regulatory submissions2.10.2023 22:27:00 CEST | Press release

Galderma, the emerging pure-play dermatology category leader, announced today updates related to the regulatory progress of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA (QM-1114) to the U.S. Food and Drug Administration (“FDA”). The FDA has issued a Complete Response Letter (“CRL”) to Galderma related to its BLA for RelabotulinumtoxinA for the treatment of moderate-to-severe glabellar lines (frown lines) associated with corrugator and/or procerus muscle activity in adult patients as well as moderate-to-severe lateral canthal lines (crow’s feet) associated with orbicularis oculi muscle activity in adult patients. The CRL points out certain deficiencies isolated to items related to Chemistry, Manufacturing, and Controls (“CMC”) processes. All other aspects of the BLA, including safety and efficacy related parts, did not solicit deficiencies to be addressed. Galderma has already identified changes to the manufacturing process to address feedback. It will also

Visa Launches $100 million Generative AI Ventures Initiative2.10.2023 22:05:00 CEST | Press release

Visa (NYSE: V), a global leader in payments, today announced a new $100 million generative AI ventures initiative to invest in the next generation of companies focused on developing generative AI technologies and applications that will impact the future of commerce and payments. As a pioneer of AI use in payments since 1993, Visa considers this initiative an extension of Visa’s leadership in using AI to drive innovation in payments, create value for partners and clients, and enable and empower global commerce. Generative AI is an emerging subset of AI that is built on Large Language Models (LLMs) to develop artificial general intelligence capable of generating text, images or other content from large sets of existing data when given prompts. “While much of generative AI so far has been focused on tasks and content creation, this technology will soon not only reshape how we live and work, but it will also meaningfully change commerce in ways we need to understand,” said Jack Forestell,